The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine-Reference-Cited by-同舟云学术

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine

Published:2003-01 Issue:1 Volume:1 Page:36-43
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Kruis Wolfgang,Bar–Meir Simon,Feher Janos,Mickisch Oliver,Mlitz Horst,Faszczyk Marek,Chowers Yehuda,Lengyele Gabriella,Kovacs Agotá,Lakatos László,Stolte Manfred,Vieth Michael,Greinwald Roland

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Sulfasalazine and 5-ASA compounds;Allgayer;Gastroenterol Clin North Am,1992

2. Alternatives to sulfasalazine: a meta-analysis of 5-ASA in the treatment of ulcerative colitis;Sutherland;Inflamm Bowel Dis,1997

3. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis;Sutherland;Ann Intern Med,1993

4. Leading article: what dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?;Riley;Gut,1998

5. Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablets and suppository dosage form;Norlander;Aliment Pharmacol Ther,1989

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orally Deliverable Microalgal-Based Carrier with Selenium Nanozymes for Alleviation of Inflammatory Bowel Disease;ACS Applied Materials & Interfaces;2024-09-12

2. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. Intestinal Inflammation and Regeneration–Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease;International Journal of Molecular Sciences;2024-01-21

4. Porphyra haitanensis polysaccharide-functionalized selenium nanoparticles for effective alleviation of ulcerative colitis;International Journal of Biological Macromolecules;2023-12

5. Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis;United European Gastroenterology Journal;2023-07-25